| scholarly article | Q13442814 |
| P356 | DOI | 10.4049/JIMMUNOL.1401108 |
| P8608 | Fatcat ID | release_4honof2iizhtxm5gme563qx5ve |
| P932 | PMC publication ID | 4490999 |
| P698 | PubMed publication ID | 26071560 |
| P50 | author | Sandra J. Hewett | Q56107151 |
| Kirsten S Evonuk | Q88448961 | ||
| Casey T. Weaver | Q41283326 | ||
| P2093 | author name string | Chander Raman | |
| Andrew Tang | |||
| Patrizia De Sarno | |||
| Tara M DeSilva | |||
| Brandi J Baker | |||
| Christine M Sestero | |||
| Bryce P Johnston | |||
| Carson E Moseley | |||
| Igor Gembitsky | |||
| Ryan E Doyle | |||
| P2860 | cites work | Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B | Q28379350 |
| Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1 | Q28592689 | ||
| Extracellular redox modulation by regulatory T cells | Q30436635 | ||
| Macrophages regulate intracellular glutathione levels of lymphocytes. Evidence for an immunoregulatory role of cysteine | Q44368023 | ||
| Nitric oxide from inflammatory-activated glia synergizes with hypoxia to induce neuronal death | Q45159494 | ||
| Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T. | Q46083107 | ||
| GluR2-free alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors intensify demyelination in experimental autoimmune encephalomyelitis | Q46097376 | ||
| Suppression of experimental autoimmune encephalomyelitis by sulfasalazine. | Q46278879 | ||
| Antenatal bacterial endotoxin sensitizes the immature rat brain to postnatal excitotoxic injury | Q46361023 | ||
| Cytokine-induced cell death in human oligodendroglial cell lines: I. Synergistic effects of IFN-gamma and TNF-alpha on apoptosis | Q47436363 | ||
| Inducible nitric oxide synthase expression in cultures enriched for mature oligodendrocytes is due to microglia | Q48107136 | ||
| Glial glutamate transport as target for nitric oxide: consequences for neurotoxicity | Q48290868 | ||
| The Mayo Clinic-Canadian Cooperative trial of sulfasalazine in active multiple sclerosis | Q48349421 | ||
| Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity | Q48510916 | ||
| Neurotransmitters in cerebrospinal fluid reflect pathological activity | Q48534847 | ||
| Inhibition of nitric oxide synthase for treatment of experimental autoimmune encephalomyelitis | Q48764891 | ||
| Cytokine modulation of glial glutamate uptake: a possible involvement of nitric oxide | Q48920499 | ||
| Cytokine-stimulated astrocytes damage human neurons via a nitric oxide mechanism | Q49077300 | ||
| System xc- and glutamate transporter inhibition mediates microglial toxicity to oligodendrocytes. | Q52578854 | ||
| Cutting edge: critical role for CD5 in experimental autoimmune encephalomyelitis: inhibition of engagement reverses disease in mice | Q53887932 | ||
| Glutamate excitotoxicity in a model of multiple sclerosis | Q60450917 | ||
| Expression of interferon-gamma receptors on murine oligodendrocytes and its regulation by cytokines and mitogens | Q61440985 | ||
| Suppression of experimental autoimmune encephalomyelitis by sulfasalazine | Q69372792 | ||
| Transport interaction of L-cystine and L-glutamate in human diploid fibroblasts in culture | Q71143449 | ||
| Interferon-gamma and interleukin-1 beta induce nitric oxide formation from primary mouse astrocytes | Q71617990 | ||
| Induction of nitric oxide synthase activity in human astrocytes by interleukin-1 beta and interferon-gamma | Q72092886 | ||
| Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide | Q72227930 | ||
| Autoimmune encephalomyelitis ameliorated by AMPA antagonists | Q73308222 | ||
| NBQX attenuates excitotoxic injury in developing white matter | Q73315790 | ||
| Delayed Antagonism of AMPA/Kainate Receptors Reduces Long-Term Functional Deficits Resulting from Spinal Cord Trauma | Q73497541 | ||
| A neuropathological analysis of experimental autoimmune encephalomyelitis with predominant brain stem and cerebellar involvement and differences between active and passive induction | Q74237342 | ||
| System x(c)- activity and astrocytes are necessary for interleukin-1 beta-mediated hypoxic neuronal injury | Q81324672 | ||
| Persistent activation of microglia is associated with neuronal dysfunction of callosal projecting pathways and multiple sclerosis-like lesions in relapsing--remitting experimental autoimmune encephalomyelitis | Q81342560 | ||
| Active immunization with proteolipid protein (190-209) induces ascending paralysing experimental autoimmune encephalomyelitis in C3H/HeJ mice | Q83102570 | ||
| Role of CB1 cannabinoid receptors on GABAergic neurons in brain aging | Q30502227 | ||
| NMDA receptor blockade with memantine attenuates white matter injury in a rat model of periventricular leukomalacia | Q33565598 | ||
| xCT deficiency accelerates chemically induced tumorigenesis | Q33779032 | ||
| Peroxynitrite generated by inducible nitric oxide synthase and NADPH oxidase mediates microglial toxicity to oligodendrocytes | Q33895965 | ||
| Slc7a11 gene controls production of pheomelanin pigment and proliferation of cultured cells | Q33901756 | ||
| Oligodendroglia metabolically support axons and contribute to neurodegeneration. | Q34032818 | ||
| Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes | Q34066077 | ||
| Regulation of glutamate transport in developing rat oligodendrocytes. | Q34080352 | ||
| T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis | Q34107156 | ||
| System xc‐ cystine/glutamate antiporter: an update on molecular pharmacology and roles within the CNS | Q34184493 | ||
| The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities. | Q34279067 | ||
| Sulfasalazine inhibits the growth of primary brain tumors independent of nuclear factor-kappaB. | Q34543666 | ||
| Increased expression of cystine/glutamate antiporter in multiple sclerosis | Q35052754 | ||
| Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria | Q35170207 | ||
| Multiple sclerosis and glutamate | Q35174585 | ||
| Regulation of system x(c)(-)activity and expression in astrocytes by interleukin-1β: implications for hypoxic neuronal injury | Q35672546 | ||
| Non-Cell Autonomous Influence of the Astrocyte System xc−on Hypoglycaemic Neuronal Cell Death | Q35744426 | ||
| CD5-dependent CK2 activation pathway regulates threshold for T cell anergy | Q36218513 | ||
| Interferon-gamma-induced oligodendrocyte cell death: implications for the pathogenesis of multiple sclerosis. | Q36437643 | ||
| Regulation and dysregulation of glutamate transporters. | Q36487971 | ||
| Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes. | Q36562441 | ||
| Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria | Q36977474 | ||
| Glutamate transporters: confining runaway excitation by shaping synaptic transmission | Q36995107 | ||
| Inhibition of cystine uptake disrupts the growth of primary brain tumors | Q37189377 | ||
| Lithium prevents and ameliorates experimental autoimmune encephalomyelitis | Q37245952 | ||
| Nitric oxide and neuronal death | Q37765041 | ||
| Type I Interferons: Beneficial in Th1 and Detrimental in Th17 Autoimmunity | Q37974525 | ||
| Emerging new roles of Th17 cells | Q38040739 | ||
| Small interfering RNA-mediated xCT silencing in gliomas inhibits neurodegeneration and alleviates brain edema. | Q39983715 | ||
| Cytokine-induced cell death in human oligodendroglial cell lines. II: Alterations in gene expression induced by interferon-gamma and tumor necrosis factor-alpha | Q40552611 | ||
| Glioma cells release excitotoxic concentrations of glutamate. | Q40929224 | ||
| The NF-κB regulator MALT1 determines the encephalitogenic potential of Th17 cells | Q41522425 | ||
| Modulation of glutamate release from rat hippocampal synaptosomes by nitric oxide. | Q42449890 | ||
| In vivo imaging of partially reversible th17 cell-induced neuronal dysfunction in the course of encephalomyelitis | Q42876667 | ||
| Dysmyelinated axons in shiverer mice are highly vulnerable to alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor-mediated toxicity | Q43246648 | ||
| Ampa/kainate receptor activation mediates hypoxic oligodendrocyte death and axonal injury in cerebral white matter. | Q43638894 | ||
| Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. | Q43715908 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 450-463 | |
| P577 | publication date | 2015-06-12 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Inhibition of System Xc(-) Transporter Attenuates Autoimmune Inflammatory Demyelination | |
| P478 | volume | 195 |
| Q90652114 | A Friend or Foe: Calcineurin across the Gamut of Neurological Disorders |
| Q40077917 | ATF3 negatively regulates cellular antiviral signaling and autophagy in the absence of type I interferons |
| Q37586538 | Absence of system xc- on immune cells invading the central nervous system alleviates experimental autoimmune encephalitis |
| Q64968764 | Amantadine Combines Astroglial System Xc- Activation with Glutamate/NMDA Receptor Inhibition. |
| Q92856155 | Clozapine Normalizes a Glutamatergic Transmission Abnormality Induced by an Impaired NMDA Receptor in the Thalamocortical Pathway via the Activation of a Group III Metabotropic Glutamate Receptor |
| Q59134975 | Connexin 30 Deficiency Attenuates Chronic but Not Acute Phases of Experimental Autoimmune Encephalomyelitis Through Induction of Neuroprotective Microglia |
| Q99711524 | Critical Neurotransmitters in the Neuroimmune Network |
| Q64095457 | Cystine-glutamate antiporter xCT deficiency suppresses tumor growth while preserving antitumor immunity |
| Q48703799 | Cystine/glutamate antiporter blockage induces myelin degeneration. |
| Q47095444 | Dendrimer-mediated delivery of N-acetyl cysteine to microglia in a mouse model of Rett syndrome |
| Q37388654 | Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination. |
| Q41682361 | Development of a primary microglia screening assay and its use to characterize inhibition of system xc- by erastin and its analogs |
| Q92050999 | Erastin Inhibits Septic Shock and Inflammatory Gene Expression via Suppression of the NF-κB Pathway |
| Q38681744 | Exploiting ROS and metabolic differences to kill cisplatin resistant lung cancer |
| Q38748236 | Fluorescence-based measurement of cystine uptake through xCT shows requirement for ROS detoxification in activated lymphocytes |
| Q91811672 | IL-1β expression is increased and regulates GABA transmission following chronic ethanol in mouse central amygdala |
| Q38954648 | Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders |
| Q38580123 | Main path and byways: non-vesicular glutamate release by system xc(-) as an important modifier of glutamatergic neurotransmission |
| Q38939753 | Mechanisms of glutamate toxicity in multiple sclerosis: biomarker and therapeutic opportunities |
| Q64118459 | Mechanisms of neurobehavioral abnormalities in multiple sclerosis: Contributions from neural and immune components |
| Q38692790 | Microglia antioxidant systems and redox signalling |
| Q37648274 | Neuropathology of mood disorders: do we see the stigmata of inflammation? |
| Q48475079 | Opposite in vivo effects of agents that stimulate or inhibit the glutamate/cysteine exchanger system xc- on the inhibition of hippocampal LTP by Aß. |
| Q37202278 | PET Imaging with [(18)F]FSPG Evidences the Role of System xc(-) on Brain Inflammation Following Cerebral Ischemia in Rats |
| Q92755064 | Recent advances of long noncoding RNAs involved in the development of multiple sclerosis |
| Q92622351 | Reduction of AMPA receptor activity on mature oligodendrocytes attenuates loss of myelinated axons in autoimmune neuroinflammation |
| Q61814347 | The Role of Neuroinflammation in Postoperative Cognitive Dysfunction: Moving From Hypothesis to Treatment |
| Q55174845 | [18F]FSPG-PET reveals increased cystine/glutamate antiporter (xc-) activity in a mouse model of multiple sclerosis. |
| Q41207747 | β1-Integrin Deletion From the Lens Activates Cellular Stress Responses Leading to Apoptosis and Fibrosis |
Search more.